Eurazeo SA (RF):企業の財務・戦略的SWOT分析

◆英語タイトル:Eurazeo SA (RF) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDFS29181FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurazeo SA (Eurazeo) is an investment service provider that offers investment services. The company offers detection and acquisition, retention and divestment and enhancement programs. It provides retention services such as CSR reporting, deployment of CSR essentials, drafting, monitoring and training and awareness consulting services. Eurazeo evaluates environmental, social and governance criteria at each stage of the investment process. The company provides mid and large scale investments, high-growth investments and real estate management. It serves consumer manufacturing, business services, media, technology and telecommunication sectors. Eurazeo is headquartered in Paris, France.

Eurazeo SA Key Recent Developments

Mar 30,2021: Eurazeo Brands signs exclusivity agreement to acquire majority of French petfood brand ultra Premium Direct
Mar 18,2021: Eurazeo enters into an exclusivity agreement with a view to acquiring Groupe Premium
Mar 08,2021: Questel signs the acquisition of NovumIP

This comprehensive SWOT profile of Eurazeo SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eurazeo SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Eurazeo SA – Key Information
Eurazeo SA – Overview
Eurazeo SA – Key Employees
Eurazeo SA – Key Employee Biographies
Eurazeo SA – Key Operational Heads
Eurazeo SA – Major Products and Services
Eurazeo SA – History
Eurazeo SA – Company Statement
Eurazeo SA – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Eurazeo SA – Business Description
Eurazeo SA – Corporate Strategy
Eurazeo SA – SWOT Analysis
SWOT Analysis – Overview
Eurazeo SA – Strengths
Eurazeo SA – Weaknesses
Eurazeo SA – Opportunities
Eurazeo SA – Threats
Eurazeo SA – Key Competitors

Section 3 – Company Financial Performance Charts

Eurazeo SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Eurazeo SA, Key Information
Eurazeo SA, Key Ratios
Eurazeo SA, Share Data
Eurazeo SA, Major Products and Services
Eurazeo SA, History
Eurazeo SA, Key Employees
Eurazeo SA, Key Employee Biographies
Eurazeo SA, Key Operational Heads
Eurazeo SA, Other Locations
Eurazeo SA, Subsidiaries

Eurazeo SA, Key Competitors
Eurazeo SA, SWOT Analysis
Eurazeo SA, Ratios based on current share price
Eurazeo SA, Annual Ratios
Eurazeo SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Eurazeo SA (RF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Huadian Power International Corporation Ltd (1071):企業の財務・戦略的SWOT分析
    Huadian Power International Corporation Ltd (1071) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • AB SKF (SKF B):企業の財務・戦略的SWOT分析
    AB SKF (SKF B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fortis Inc.:企業の戦略・SWOT・財務情報
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • East Japan Railway Co:戦略・SWOT・企業財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Viasat Inc
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Middle East Airlines:企業の戦略・SWOT・財務情報
    Middle East Airlines - Strategy, SWOT and Corporate Finance Report Summary Middle East Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Abu Dhabi National Energy Co (TAQA):石油・ガス:M&Aディール及び事業提携情報
    Summary Abu Dhabi National Energy Company (TAQA), a subsidiary of government-owned Abu Dhabi Water and Electricity Authority, is an energy and water company. It undertakes power generation; exploration, development, production and storage of oil and gas; pipelines and gas storage; and water desalina …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PharmaLundensis AB:医療機器:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Imerys SA:企業のM&A・事業提携・投資動向
    Imerys SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imerys SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Delphi Energy Corp (DEE):企業の財務・戦略的SWOT分析
    Delphi Energy Corp (DEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fisher & Paykel Appliances Holdings Limited:企業の戦略的SWOT分析
    Fisher & Paykel Appliances Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Fortum Corporation (FORTUM):電力:M&Aディール及び事業提携情報
    Summary Fortum Corporation (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power pl …
  • University of Louisville-製薬・医療分野:企業M&A・提携分析
    Summary University of Louisville (UofL) is an educational university that offers undergraduate, graduate, post-baccalaureate pre-med program, dentistry, law and online programs. The university offers courses such as accountancy, aerospace studies, art education, bioengineering, business administrati …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆